On the HCPLive Major Depressive Disorder condition center page, resources on the topics of medical news and expert insight into depression can be found. Content includes articles, interviews, videos, podcasts, and breaking news on MDD research, treatment, and drug development.
October 23rd 2024
Alto Neuroscience's ALTO-100 failed to beat placebo in a phase 2b trial for depression, leading to a 60% stock drop.
October 23rd 2024
Placebo, Nocebo Reactions Confound Antidepressant Trials for Persistent Depression
June 20th 2017A new meta-analysis found that 31 percent of patients in antidepressant treatment trials for persistent depressive disorder (PDD) responded to placebo and 57 percent reported adverse (nocebo) effects to them.